inVentiv, Median strategic alliance brings biomarker imaging to clinical trials
Median Technologies will provide inVentiv Health clients with various integrated imaging services to support clients at all stages of development.
Archives for April 10, 2017
Ohr Pharmaceutical says it has funds to complete PhIII eye drug trial
Ohr Pharmaceutical has raised enough money to complete a Phase III trial of its AMD drug - Squalamine – just days after NASDAQ officials gave it 180 days to regain the exchange’s minimum listing price.
CRO Accelovance launches oncology-focused initiative
Accelovance has launched a global initiative dedicated to advancing early phase oncology therapies – an “underserved focus of CROs,” it says.
EMA sets up inbox for pharma whistle-blowers and adopts investigation policy
The EMA has set up an email inbox for drug company employees who report improper manufacturing and trial activities.
Theradex tapped as CRO for Ph I/II AML trial
Moleculin Biotech has hired Theradex for its upcoming Phase I/II clinical trial for its lead candidate, Annamycin.
Providers consolidate as VWR acquires MESM
VWR has acquired MESM in order to provide customers with end-to-end product and supply chain solutions.